Starting a GLP-1 over 60 is a different decision than starting one at 35. The medications are the same — semaglutide produced about 14.9% average weight loss over 68 weeks in the STEP 1 trial, and tirzepatide up to about 20.9% over 72 weeks in SURMOUNT-1 — but the stakes around them shift with age. You have less muscle you can afford to lose, your kidneys tolerate dehydration less well, and your medication list is probably longer than it was twenty years ago.
There is also a money problem specific to this age group: Medicare generally does not cover GLP-1s prescribed for weight loss alone (Part D plans cover these drug families for diabetes indications, like Ozempic prescribed for type 2 diabetes). Most people over 60 will pay cash — anywhere from $99 to $449 per month at the five programs below. Because a careless prescription is more dangerous at this age than a pricey one, we ranked these providers by screening quality first, price second.
1. Ro — The Strictest Screening in Online Weight Loss
Ro earns the top spot for older adults on one unusual rule: its help center states that you must have seen a healthcare provider within the last 3 years to use the service. That single requirement means Ro’s clinicians are prescribing to people with a recent medical record behind their answers — not just a self-reported questionnaire. Everything Ro ships is FDA-approved and brand-name (Wegovy, Zepbound, and the new oral options), sourced through Novo Nordisk’s NovoCare and Eli Lilly’s LillyDirect channels, with an eligibility decision typically within about 2 days.
Pricing Structure
Ro bills membership and medication separately. Membership is $39 the first month, then $149/month — or as low as about $74/month if you prepay a year — and it is only charged if a clinician finds you eligible. Cash medication prices: Wegovy pen $199 the first month, then $199–$399/month by dose; Zepbound KwikPen $299 first month, then $399–$449; Wegovy and Foundayo pills $149 first month, then $199–$299 (pills are cash-pay only). Ro’s free insurance checker and prior-authorization concierge are worth using even at this age: Medicare rarely helps with weight-loss GLP-1s, but retiree and employer plans sometimes do, and with coverage the medication can drop to a copay.
Pros & Cons
Pros: FDA-approved medication only, with no compounded products on the July 2026 menu. 24/7 care-team access and unlimited provider messaging — valuable when a new side effect shows up at 9 p.m. Serves all 50 states plus D.C., and the insurance concierge does paperwork most competitors leave to you.
Cons: Without insurance, realistic maintenance-dose costs run $350+ per month once membership is added, and the medication price climbs with dose. Ro’s BBB profile shows a B rating with 610 complaints, many about membership billing clarity, and Trustpilot sits around 3.7/5. Get the full billing picture in our Ro review.
2. Noom Med — Coaching That Helps Protect Muscle
Rapid weight loss takes lean mass along with fat, and after 60 that muscle is hard to win back. Noom Med is the only program here that bundles a full behavior-change platform — 1:1 coaching, food logging, and a structured curriculum — with the prescription, which gives you built-in support for the protein tracking and habit changes clinicians commonly recommend during treatment. The medication itself is compounded semaglutide or tirzepatide, which is not FDA-approved; Noom says it comes from an FDA-regulated 503B outsourcing facility.
Pricing Structure
Compounded semaglutide costs $129 the first month, then $249/month billed quarterly — roughly $747 every 12 weeks after month one, a lump sum worth planning around on a fixed income. A Microdose tier starts at $79 the first month (then $199/month per the pricing hub, though a product page showed $179 the same week — an inconsistency we flagged in July 2026). Compounded tirzepatide runs $149 first month, then $299/month. A brand-name pathway costs $39 the first month, then $99/month, plus the drug itself through insurance or cash. Noom does not state whether the compounded price changes as your dose titrates.
Pros & Cons
Pros: BBB A+ rating, accredited since 2021, from a company operating since 2008. The Taper-Off Guarantee offers a year of free Noom or medication discounts if weight returns within 18 months after completing its 12-month protocol. Plans are FSA/HSA eligible and cancel anytime.
Cons: Compounded GLP-1s are not FDA-reviewed for safety, efficacy, or quality — Noom’s own disclaimer says so. The compounded plans are unavailable in Alabama, Louisiana, and Mississippi, and quarterly billing surprises people who expected a small monthly charge. Full pricing math is in our Noom Med review.
3. Hers — Pills and Brand-Name Pens, No Lab Work
For women over 60 who dread a weekly injection — or whose hands make pens awkward — Hers offers oral GLP-1 options from $149/month, alongside brand-name Wegovy pens and Zepbound. The women’s brand of NYSE-listed Hims & Hers moved its program to FDA-approved brand-name medication after a bruising 2025, and its asynchronous visits require no lab work and no video call in most states — a gentle on-ramp if telehealth is new to you.
Pricing Structure
Medication requires a Hers Weight Loss Membership: $39 the first month, then $149/month, billed separately. On top of that, Wegovy, Ozempic, and Foundayo pills start from $149/month; Wegovy pens from $199; Zepbound from $299. Per third-party pricing reports from July 2026, the cheapest realistic combination lands around $303/month ongoing. These are advertised as starting prices that rise at higher doses, and Hers does not publish a full dose-by-dose table. Insurance is not accepted at all — every dollar is out of pocket.
Pros & Cons
Pros: BBB A+ rating with about 3.8/5 across roughly 7,000 customer reviews. Provider review typically within 24 hours, with ongoing messaging for dose changes. The pill options are a genuine advantage for anyone with arthritis, tremor, or needle anxiety.
Cons: Hers states plainly that the membership fee does not include or guarantee a prescription. The company received an FDA warning letter in September 2025 over misleading compounded semaglutide marketing and was sued by Novo Nordisk in February 2026. Refunds are limited to a 48-hour window on unshipped initial orders, and canceling medication does not cancel the membership — details in our Hers review.
4. bmiMD — Predictable Flat Pricing for Retirement Budgets
If you are budgeting on Social Security and savings, bmiMD’s appeal is that the number never moves: compounded semaglutide at $99–$129/month with the same price at every dose, no membership fee, and everything bundled — visit, medication, unlimited provider messaging, and shipping. The trade-off is that this New York telehealth company (operating since late 2022) sells compounded medication only, which is not FDA-approved, and its screening is a same-day telehealth consult that happens after you place an order.
Pricing Structure
Semaglutide runs $129/month month-to-month, $119 on a 3-month plan, $109 on 6 months, and $99/month on a 12-month plan billed $1,188 upfront — think of that as a year of treatment paid like an insurance premium. Tirzepatide costs $139–$159/month by plan length, with an $89.50 first-month promo for new members. Your card is authorized but not charged until a provider approves you, and ineligible applicants pay nothing.
Pros & Cons
Pros: bmiMD publishes quality-testing claims most budget rivals skip: potency verified within ±10% every 3–6 months, USP 797 sterility, and USP 85 endotoxin testing through FDA- and DEA-registered labs. Trustpilot sits around 4/5 across roughly 800 reviews, and HSA/FSA cards are accepted.
Cons: All sales are final once the pharmacy processes an order, and canceling between intake approval and pharmacy processing costs a $50 fee — unforgiving if a family doctor later advises against treatment. BBB rates the company C+ with 38 complaints, and its compounding pharmacies are not named. Our bmiMD review weighs whether the $99 rate is worth the upfront commitment.
5. MEDVi — Tablets Without Needles, but Watch the Billing
MEDVi lands last on this list not because of price — its flat $299/month refill rate is fair — but because its screening and complaint record fit older adults worst. The intake is a short asynchronous questionnaire reviewed through the OpenLoop Health clinician network, and the Delaware company’s BBB rating is F, with 662 complaints and 100 left unanswered. Its standout feature for this audience is real: daily dissolvable semaglutide tablets for anyone whose eyesight, tremor, or arthritis makes weekly self-injection a genuine obstacle.
Pricing Structure
Compounded semaglutide injections cost $179 the first month, then a flat $299/month that does not rise with dose. Dissolvable tablets start at $249 the first month, with refill pricing unpublished (third-party reviews cite up to $369). Compounded tirzepatide starts around $349, with refills reported by third parties at $399–$499 depending on dose. One review site reports billing on a 28-day cycle — about 13 charges per year instead of 12, which quietly adds a full extra month of cost annually.
Pros & Cons
Pros: MEDVi names its compounding pharmacies publicly (Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding) — transparency many rivals refuse. Trustpilot shows about 4.4/5 across roughly 14,000 reviews, shipping is free and expedited, and HSA/FSA payments are accepted.
Cons: Recurring BBB and Trustpilot complaints describe unauthorized auto-renewal charges (often $399), double billing, and difficulty canceling — patterns that demand extra vigilance with any recurring charge on a retirement account. Refunds are generally unavailable once medication is dispensed, and the compounded products are not FDA-approved, as MEDVi’s own site discloses. We unpack the split reputation in our MEDVi review.
How Did We Rank These GLP-1 Over 60 Programs?
Every score comes from the public 5-factor rubric on our How We Rank page — pricing transparency (30%), total cost (25%), safety and sourcing disclosure (20%), service flexibility (15%), and reputation (10%) — applied to provider websites, BBB files, Trustpilot records, and FDA correspondence we checked in July 2026. For this GLP-1 over 60 comparison, we paid special attention to intake depth: whether a provider demands real medical history (Ro’s 3-year doctor-visit rule), whether it reviews your medication list carefully, and whether its billing practices would trip up someone managing a fixed income. These are editorial ratings built from documented research. We do not test medications ourselves, and the affiliate relationships disclosed on this page never change a score.
Is Taking a GLP-1 Over 60 Safe? Muscle, Kidneys, and Your Med List
Three age-specific issues should shape the conversation with your prescriber before the first dose of a GLP-1 over 60.
Muscle loss is the number-one concern
Weight lost quickly is never pure fat — some of it is lean mass, and after 60 the body rebuilds muscle slowly. Clinicians commonly recommend two countermeasures during treatment: protein at every meal (many suggest setting a daily protein target with your provider) and resistance training 2–3 times per week — bands, light weights, or bodyweight exercises all count. Ask about a slower dose escalation too; the Wegovy label already steps the dose up gradually from 0.25 mg toward 2.4 mg over about four months, and appetite suppression that is too aggressive can crash your food intake below what muscle maintenance needs.
Kidneys and dehydration
The most common GLP-1 side effects are digestive — nausea, vomiting, and diarrhea — and drug references such as Mayo Clinic warn that the dehydration they cause can worsen kidney problems. Older kidneys have less reserve. Disclose any kidney disease during intake, keep fluids steady, and treat persistent vomiting or diarrhea as a call-the-provider event, not something to push through. Our GLP-1 side effects guide lists the symptoms that justify stopping and seeking care.
Drug interactions get more likely with every prescription
Two interaction patterns matter most. If you take insulin or a sulfonylurea for diabetes, adding a GLP-1 can push blood sugar too low, so dosing may need adjustment. And because GLP-1s slow stomach emptying, they can change how some oral medications absorb. The practical rule: your intake form should list every prescription, supplement, and over-the-counter product you take — and a provider that asks detailed follow-up questions about that list is showing you its screening is real. The usual disqualifiers also still apply at any age: a personal or family history of medullary thyroid carcinoma or MEN 2, prior pancreatitis, or an active eating disorder.
Does Medicare Pay for GLP-1 Weight Loss Treatment?
For weight loss alone, generally no — and that single fact shapes the entire GLP-1 over 60 market. Here is how the payment picture typically breaks down:
| Payment route | What usually happens |
|---|---|
| Medicare Part D, weight loss alone | Generally not covered |
| Medicare Part D, diabetes indication | Can cover GLP-1s prescribed for type 2 diabetes (e.g., Ozempic, Mounjaro) |
| Employer or retiree commercial plan | Sometimes covers Wegovy or Zepbound with prior authorization |
| Cash-pay telehealth | $99–$299/mo compounded semaglutide; $149–$449/mo brand-name plus any membership |
Two takeaways. First, never assume coverage: run Ro’s free insurance check or call the number on your drug card before committing to any plan, and read our guide on whether insurance covers GLP-1s for the prior-authorization playbook. Second, if you are paying cash, price the whole year, not the first month: a $179 teaser that becomes $299, a $149/month membership on top of medication, or a 13-cycle billing year can double what the headline price suggested.
What Should You Expect From the Online Sign-Up Process?
The mechanics are the same at every provider: a 10–20 minute health questionnaire, review by a state-licensed clinician (asynchronously in most states, by video where law requires), then medication shipped to your door in roughly 2–7 days if you are approved. At this age, treat the questionnaire as a medical document — complete medication list, honest kidney and heart history, recent surgeries — because the clinician can only screen what you disclose.
If you are approved for an injectable, the weekly routine is simpler than most people fear: prefilled pens like Wegovy involve no drawing of doses, and our step-by-step guide on how to inject semaglutide covers site rotation, storage, and what to do about missed doses. If dexterity or vision makes any needle a bad idea, the pill route at Ro or Hers, or MEDVi’s dissolvable tablets, removes that barrier entirely — at the cost, in MEDVi’s case, of a daily rather than weekly schedule.
One final filter: a trustworthy provider will sometimes tell you no. Programs that reject unqualified applicants, require recent medical care, or ask follow-up questions about your medication list are the ones taking a 67-year-old patient seriously. A website that would prescribe to anyone with a credit card is exactly the one to avoid — at any age, but especially now.